Evidence map›Paper›PMID 41073365›Full record

ArticleCardiovascular research2025

Cardiovascular risk factors and the allostatic interoceptive network in dementia.

Jessica L Hazelton, Joaquín Migeot, Raul Gonzalez-Gomez, Florencia Altschuler, Claudia Duran-Aniotz, Olivia Wen, Dante Sebastián Galván Galván Rial, Pablo Barttfeld, Vicente Medel, Cecilia González Campo and 28 more

Abstract readMulticenter Study
In one paragraph

Article in Cardiovascular research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Benchmarking speech biomarkers of Alzheimer's against cognitive and neural measures.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  5. Neural embedding of frailty in cognitively unimpaired aging and dementia across Latin America.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

38 authors.

Jessica L HazeltonLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.ORCID 0000-0002-0784-6071
Joaquín MigeotLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.ORCID 0000-0003-0647-5632
Raul Gonzalez-GomezLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.ORCID 0000-0003-2341-011X
Florencia AltschulerLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.
Claudia Duran-AniotzLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.ORCID 0000-0003-2503-8366
Olivia WenGlobal Brain Health Institute (GBHI), Trinity College Dublin, Dublin, Ireland.
Dante Sebastián Galván Galván RialLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.
Pablo BarttfeldLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.
Vicente MedelLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.ORCID 0000-0003-2443-8683
Cecilia González CampoLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.
Ana María Castro-LaguardiaLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.
Hernán HernándezLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.
Carolina Gonzalez-SilvaLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.ORCID 0000-0002-0866-5723
Olga CastanerGlobal Brain Health Institute (GBHI), Trinity College Dublin, Dublin, Ireland.
Kun HuDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Peng LiDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-4684-4909
María Isabel BehrensDepartamento de Neurociencia, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Martin A BrunoInstituto de Ciencias Biomédicas, Universidad Católica de Cuyo, San Juan, Argentina.
Juan Felipe CardonaFacultad de Psicología, Universidad del Valle, Cali, Colombia.ORCID 0000-0001-6795-7753
Nilton CustodioUnit Cognitive Impairment and Dementia Prevention, Peruvian Institute of Neurosciences, Lima, Peru.ORCID 0000-0002-8025-3272
Hernando Santamaria-GarciaPontificia Universidad Javeriana, PhD Program of Neuroscience, Bogotá, Colombia.ORCID 0000-0001-9422-3579
Adolfo M GarciaCognitive Neuroscience Center (CNC), Universidad de San Andrés, Buenos Aires, Argentina.
Maria E GodoyLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.
José Alberto Avila-FunesDirección de Enseñanza, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID 0000-0003-0033-5508
Marce MaitoLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.
Diana L MatallanaInstituto de Envejecimiento, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá D.C., Colombia.
Bruce MillerGlobal Brain Health Institute, University of California, San Francisco, California, USA.ORCID 0000-0002-2152-4220
Francisco LoperaGrupo de Neurociencias de Antioquia, University of Antioquia, Medellín, Colombia.
Maira Okada de OliveiraDepartamento de Lingüística y Literatura, Universidad de Santiago de Chile, Santiago, Chile.
Stefanie D Pina-EscuderoGlobal Brain Health Institute, University of California, San Francisco, California, USA.
Katherine L PossinGlobal Brain Health Institute, University of California, San Francisco, California, USA.
Elisa de Paula France ResendeGlobal Brain Health Institute, University of California, San Francisco, California, USA.
Pablo ReyesInstituto de Envejecimiento, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá D.C., Colombia.
Andrea SlachevskyFaculty of Medicine, University of Chile, Santiago, Chile.ORCID 0000-0001-6285-3189
Ana Luisa SosaLaboratorio de Demencias del Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City, CDMX, México.
Leonel T TakadaGrupo de Neurociencias de Antioquia, University of Antioquia, Medellín, Colombia.
Jennifer S YokoyamaGlobal Brain Health Institute, University of California, San Francisco, California, USA.ORCID 0000-0001-7274-2634
Agustin IbanezLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.ORCID 0000-0001-6758-5101

Funding

TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
An automated machine learning approach to language changes in Alzheimer’s disease and frontotemporal dementia across Latino and English-speaking populationsR01AG075775 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARIA LUISA GORNO TEMPINI, Adolfo Martin Garcia · 2023 to 2026
$7.2M
US-South American Initiative for Genetic-Neural-Behavioral Interactions in Human Neurodegenerative ResearchR01AG057234 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Claudia Duran-Aniotz, Agustin M. Ibanez · 2019 to 2026
$6.1M
Circadian Disturbance and Dementia in Latin AmericaR01AG083799 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Kun Hu, Agustin M. Ibanez · 2023 to 2026
$3.0M
Alzheimer's Association AARGD-24- 1310017ANID ANID/PIA/ANILLOS ACT210096ANID FONDECYT Regular 1210622CONICETFogarty International Center (FIC)FONDECYT Regular 1210176FONDECYT Regular 1210195FONDECYT Regular 1220995FONDECYT Regular ANID/FONDAP 15150012FONDECYT Regular ANID/FONDAP/15150012FONDECYT Regular ANID/PIA/ANILLOS ACT210096FONDECYT Regular FONDEF ID20I10152FONDECYT Regular ID22I10029FONDECYT Regular Takeda CW2680521FOVI240065GBBHI fellowship 2024Global Brain Health InstituteISCIII CP21/00097ISCIII P20/00012ISCIII PI24/00326MULTI-PARTNER CONSORTIUM TO EXPAND DEMENTIA RESEARCH IN LATIN AMERICAmulti-partner consortium to expand dementia research in Latin America (ReDLat)National Institutes of Aging R01 AG021051National Institutes of Aging SG-20-725707NIA NIH HHS P01 AG019724NIA NIH HHS R01 AG057234NIA NIH HHS R01 AG075775NIA NIH HHS R01 AG083799NIH HHSRainwater Charitable Foundation
6 · The paper itself

Abstract

aimsCardiovascular risk factors, such diabetes, hypertension, blood pressure, obesity, and smoking, are linked with allostatic-interoception-the continuous monitoring of internal bodily states in anticipation of environmental demands. These risk factors are associated with dementia risk. How these factors affect brain networks vulnerable to neurodegeneration and involved in allostatic-interoception, such as the Allostatic-Interoceptive Network (AIN), is unknown. We investigated the relationship between cardiovascular risk and AIN structure and function in frontotemporal lobar degeneration (FTLD) and Alzheimer's disease (AD). METHODS AND

resultsWe recruited 1501 participants (304 with FTLD, 512 with AD, and 685 healthy controls) from the Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat). A cardiovascular risk score was calculated based on: age, sex, diabetes, hypertension, systolic blood pressure, body mass index, and smoking status. Cardiovascular risk was associated with grey matter integrity and functional connectivity in age- and sex-matched patient-control groups focusing on predefined regions of interest within the AIN. Higher cardiovascular risk was associated with reduced structural integrity and functional connectivity within the AIN in both FTLD and AD. FTLD patients showed more extensive structural and functional connectivity disruptions throughout the AIN. In AD patients, structural reductions in the AIN were prominent, with functional connectivity restricted to the hippocampus, parahippocampal gyrus, and orbitofrontal regions.

conclusionCardiovascular risk factors appear to adversely impact the AIN structure and function, with disease-specific patterns of vulnerability. Results underscore the importance of integrating cardiovascular health into models of neurodegenerative disease and managing cardiovascular health to support brain integrity in dementia.

Indexed as

AllostasisAlzheimer DiseaseBrainCardiovascular DiseasesInteroceptionAgedAged, 80 and overCase-Control StudiesConnectomeFemaleHeart Disease Risk FactorsHumansMagnetic Resonance ImagingMaleMiddle AgedRisk AssessmentAgingBrain atrophyCardiovascular healthCardiovascular riskDementiaFunctional connectivityNeurodegeneration

Identifiers

PMID41073365
PMCPMC12638725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.